Dimensional Fund Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Dimensional Fund Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,131	Closed	-$54K	–	3413
2019 Q3	$54K	Sell	5,131 -27,075	-84%	-$354K	﹤0.01%	3380
2019 Q2	$547K	Buy	32,206 +15,286	+90%	+$414K	﹤0.01%	3175
2019 Q1	$570K	Buy	16,920 +8,068	+91%	+$270K	﹤0.01%	3143
2018 Q4	$258K	Hold	8,852	–	–	﹤0.01%	3249
2018 Q3	$545K	Buy	+8,852	New	+$599K	﹤0.01%	3166
2018 Q2	–	Sell	-4,052	Closed	-$266K	–	3387
2018 Q1	$266K	Sell	4,052 -175	-4%	-$13.2K	﹤0.01%	3192
2017 Q4	$355K	Hold	4,227	–	–	﹤0.01%	3142
2017 Q3	$488K	Buy	4,227 +171	+4%	+$18K	﹤0.01%	3111
2017 Q2	$474K	Buy	+4,056	New	+$503K	﹤0.01%	3100

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's BLCM Position: Q4 2019 in Review

Dimensional Fund Advisors sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2019, closing a stake of 5,131 shares — an estimated $54K sold.

Dimensional Fund Advisors first reported a position in BLCM in Q2 2017 and held it in 9 quarters. The position peaked at $570K in Q1 2019. 51 funds tracked by Wall St. Rank hold BLCM as of Q4 2019.

Dimensional Fund Advisors reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Dimensional Fund Advisors sold 5,131 Bellicum Pharmaceuticals, Inc. shares in Q4 2019, an estimated $54K.
Dimensional Fund Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2017 and held it in 9 quarters.
Dimensional Fund Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $570K in Q1 2019.
51 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2019.

Based on Dimensional Fund Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.